Cara E Toscan 35th Lorne Cancer Conference 2023

Abstracts this author is presenting:

• A novel approach to the treatment of T-cell acute lymphoblastic leukaemia using the AKR1C3-activated prodrug, ACHM-025 — Session 5: Immunotherapy and immune evasion